Nursing homes residents who use continuous glucose monitors (CGMs) to track their daily blood sugar levels would see their Medicare coverage and payments for the devices expanded under a new proposed rule by the federal government. The Centers for Medicare & Medicaid Services on Tuesday announced a proposal for several new changes to Medicare Durable…
While President Donald Trump would seek to cap the overall federal contribution to Medicaid and increase state flexibility, former Vice President Joe Biden would look to expand the program to provide more funding to long-term care services, reveals a new analysis on the presidential candidates’ proposals for seniors.
Rural Medicare recipients with Alzheimer’s and related dementias have longer nursing home stays and shorter survival time following diagnosis than their urban peers, investigators say.
Four of the nation’s top provider groups representing long-term care, home health and hospitals are calling on Congress to extend a moratorium on the 2% Medicare sequester cuts into 2021 and for the duration of the coronavirus pandemic.
Fully 21% of beneficiaries have forgone needed healthcare for something other than COVID-19. Nearly half say they did not want to risk being at a medical facility, according to CMS.
Laboratories that process coronavirus diagnostic tests within two calendar days will receive a higher Medicare reimbursement than those that take longer, the Centers for Medicare & Medicaid Services announced Thursday.
Many of the new services involve cardiovascular care, including intensive cardiac rehab with and without exercise, pulmonary rehab with exercise, and in-person ventricular assist device interrogation.
Providers who participated in the Medicare Accelerated and Advanced Payment Program for COVID-19 emergency will now have another year to pay back the loan thanks to Congress.
The Centers for Medicare & Medicaid Services has yet to ask for loan repayments from providers that participated in its advanced Medicare payment program.
Long-term care pharmacies could soon be facing “significant ramifications in the long run” following an executive order signed by President Trump on Sunday. That directive states that the Medicare program should not pay more for Part D prescription drugs than the lowest price. More still needs to be known about possible effects, experts caution.
